Topical gel compositions for the treatment of Staphylococcal infections
US10912759B2 · kind B2 · utility
0Cited by
1References
13Claims
0Family size
Inventor
Key dates
| Filing date | May 17, 2019 |
| Grant date | Feb 9, 2021 |
| Priority date | — |
| Expiry date | May 17, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating a methicillin-resistant Staphylococcus aureus (MRSA) infection or a Staphylococcus pseudintermedius infection in subject in need thereof are provided, the methods comprising administering to the subject an effective amount of a topical gel composition comprising vitamin E d-alpha-tocopherol polyethylene glycol 1000 succinate (TPGS); and at least one lipophile. Compositions, methods of manufacture, and methods of use in inhibiting microbial growth are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.